Faster global financial news!
Deutsche Bank Rates AstraZeneca 'Sell' with 11,500p Target, Despite Positive Tozorakimab Lung Disease Data and Over $5 Billion Peak Sales Outlook
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
The bank raised its 2027 humanoid robot sales forecast for Unitree Robotics to 31,701 units
-
2
Meta's earnings triggered a significant widening of AI credit spreads, with its Credit Default Swaps (CDS) reaching an all-time high
-
3
shows that the computational power consumption for training humanoid robot full-body motion controllers can be compressed by over 1000 times
-
4
RADR Token (Solana Chain) Analysis: Trading Channels and Market Status
-
5
Cryptocurrency Basics: Definition, Development, and Secure Investment Strategies
-
6
Toncoin Institutional Investor Analysis: Funding, Custody, and Market Impact of the Telegram Ecosystem
-
7
Ethereum Monetary Theory: From EIP-1559 to the "Ultra Sound Money" Vision
-
8
AI, a Chinese provider of high-quality AI token production services, recently completed a Series B funding round exceeding RMB 1.3 billion
-
9
Boosted by this news, SK Hynix's stock price rose over 2% at one point on Monday
-
10
DEXI (Dexioprotocol) Status Analysis: Version Migration, Data Metrics, and Trading Activity
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
